Real Chemistry Acquires Greater Than One

Real Chemistry has acquired Greater Than One, a healthcare agency known for its data-driven media technology, predictive planning, and omnichannel execution. The deal enhances Real Chemistry’s existing analytics and creative platform—positioning the combined organization to better serve pharmaceutical clients with precision and performance at scale. 

This marks Real Chemistry’s first major acquisition under its continuation fund with New Mountain Capital and reflects the agency’s growing investment in technology-led strategy. 

Why it may matter 

Predictive planning tools: Greater Than One brings a suite of proprietary tools that Real Chemistry intends to incorporate into its operations, including: 

• Greater Reach, positioned for forecast-based media planning 

• Greater Score, designed to provide HCP engagement insights 

• Greater Omni, which seeks to support omnichannel campaign activation 

Potential for expanded capability: Real Chemistry appears to be positioning these tools as part of a broader integration across its existing functions, which include creative, influencer strategy, medical affairs, and market access. 

Leadership continuity: CEO Elizabeth Apelles is expected to remain in her role, with Amanda Powers-Han named as her planned successor in 2026. 

Integration with purpose 

Greater Than One will continue operating from its New York headquarters with a remote-first model. The agency joins Real Chemistry’s platform while retaining cultural independence—focused...